Los puntos clave no están disponibles para este artículo en este momento.
We have identified CCL3 as a potential target to modulate the inflammatory response and secondary damage after SCI. Collectively, this study shows that CCL3 contributes to progressive tissue damage and functional impairment during secondary injury after SCI.
Pelisch et al. (Fri,) studied this question.